Literature DB >> 20088819

Review of treatment for cocaine dependence.

Jennifer K Penberthy1, Nassima Ait-Daoud, Michelle Vaughan, Tasmin Fanning.   

Abstract

Cocaine dependence is a complicated, destructive, and often chronic illness that is difficult to treat. In this article we review the challenges in treating cocaine dependence, as well as recent developments and future directions in psychosocial and pharmacological treatment relevant to treatment of cocaine dependence. Cocaine is one of the most addictive drugs because of its immediate and powerful rewarding effects. Often, cocaine dependent individuals experience difficulty abstaining due to cognitive impairments from repeated cocaine use, strong use-related social and environmental cues, and high levels of life stress. Cocaine use also affects areas of the brain related to motor function, learning, emotion, and memory, further complicating the administration of effective interventions. In addition, development of treatments for cocaine dependence has been complicated by the tendency for abusers not to complete treatment programs and their propensity for relapse. Despite these challenges, some treatment approaches, such as cognitive behavioral therapy (CBT) and medications have shown promise in successfully treating cocaine dependence. However, individually, each of these treatments exhibit weakness in longitudinal studies where long-term abstinence is the primary outcome of interest. Although other treatments are being explored, thus far, the combination of CBT and pharmacotherapy has elicited the best results for treating cocaine dependence with respect to patient retention and relapse prevention following abstinence. No treatment method has yet been shown to completely and effectively treat cocaine dependence. More research is necessary to test treatment programs and garner further information in order to better understand and treat cocaine dependence.

Entities:  

Mesh:

Year:  2010        PMID: 20088819     DOI: 10.2174/1874473711003010049

Source DB:  PubMed          Journal:  Curr Drug Abuse Rev        ISSN: 1874-4737


  35 in total

1.  Contingency management for patients with dual disorders in intensive outpatient treatment for addiction.

Authors:  Thomas M Kelly; Dennis C Daley; Antoine B Douaihy
Journal:  J Dual Diagn       Date:  2014

Review 2.  Accelerating cocaine metabolism as an approach to the treatment of cocaine abuse and toxicity.

Authors:  Charles W Schindler; Steven R Goldberg
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

3.  Differential effects of dorsal hippocampal inactivation on expression of recent and remote drug and fear memory.

Authors:  J D Raybuck; K M Lattal
Journal:  Neurosci Lett       Date:  2014-03-28       Impact factor: 3.046

4.  Chemogenetic inhibition of direct pathway striatal neurons normalizes pathological, cue-induced reinstatement of drug-seeking in rats.

Authors:  Lindsay M Yager; Aaron F Garcia; Elizabeth A Donckels; Susan M Ferguson
Journal:  Addict Biol       Date:  2018-01-05       Impact factor: 4.280

5.  Cocaine use in the past year is associated with altitude of residence.

Authors:  Kristen K Fiedler; Namkug Kim; Douglas G Kondo; Perry F Renshaw
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

6.  Comparable efficacy of behavioral and pharmacological treatments among African American and White cocaine users.

Authors:  LaTrice Montgomery; Kathleen M Carroll
Journal:  J Ethn Subst Abuse       Date:  2017-04-25       Impact factor: 1.507

7.  Paradoxical abatement of striatal dopaminergic transmission by cocaine and methylphenidate.

Authors:  Mauro Federici; Emanuele Claudio Latagliata; Ada Ledonne; Francesca R Rizzo; Marco Feligioni; Dave Sulzer; Matthew Dunn; Dalibor Sames; Howard Gu; Robert Nisticò; Stefano Puglisi-Allegra; Nicola B Mercuri
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

8.  The histone deacetylase inhibitor sodium butyrate modulates acquisition and extinction of cocaine-induced conditioned place preference.

Authors:  Jonathan D Raybuck; Ellen J McCleery; Christopher L Cunningham; Marcelo A Wood; K Matthew Lattal
Journal:  Pharmacol Biochem Behav       Date:  2013-02-27       Impact factor: 3.533

9.  Integrating buprenorphine maintenance therapy into federally qualified health centers: real-world substance abuse treatment outcomes.

Authors:  Marwan S Haddad; Alexei Zelenev; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2013-01-17       Impact factor: 4.492

10.  Pharmacokinetics and Safety Assessment of l-Tetrahydropalmatine in Cocaine Users: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Hazem E Hassan; Deanna Kelly; Moshe Honick; Sagar Shukla; Ahmed Ibrahim; David A Gorelick; Matthew Glassman; Robert P McMahon; Heidi J Wehring; Ann Marie Kearns; Stephanie Feldman; Mingming Yu; Ken Bauer; Jia Bei Wang
Journal:  J Clin Pharmacol       Date:  2016-08-04       Impact factor: 3.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.